From idea to safe product

Animal studies (rodents and mini pig) from experimental/MoA to regulatory (GLP) safety studies (all routes of administration), toxicology specialist guidance from drug discovery to clinic incl e.g. predictions performed by computation-based in silico programs, some tools are developed in-house based on artificial intelligence (AI) technique, in vitro and in vivo models. Analyses and methodologies related to bioanalysis, ADME and pharmacokinetics (PK), protein characteristics, histopathology and pathology, inflammatory and immune response. Industrial pharmaceutical experience and regulatory risk and target safety assessments. Also biocompatibility and toxicological assessments (medical devices).